IM Cannabis Expands Leadership and Secures $2 Million Loan Agreement

IM Cannabis Expands Leadership and Secures $2 Million Loan Agreement



On July 9, 2025, IM Cannabis Corp. (NASDAQ: IMCC), a prominent player in the medical cannabis sector with operations spanning Israel and Germany, announced the signing of a critical loan agreement alongside the appointment of Oz Adler to its board of directors. This strategic move is designed to bolster the company's growth initiatives and strengthen its positioning in the ever-evolving medical cannabis industry.

Oz Adler Joins the Board of Directors


Mr. Oz Adler brings a wealth of experience to the IM Cannabis board, effective July 6, 2025. His profound expertise in financial oversight and strategic growth, coupled with a strong background in regulatory compliance and public company governance, positions him as a valuable asset for the company's future endeavors. Adler is currently involved with several publicly traded entities, enhancing his relevance to IMC's vision for disciplined growth and sustainable profitability.

CEO Oren Shuster expressed excitement at Adler's appointment, emphasizing his extensive knowledge in capital markets and corporate finance, particularly in the pharmaceutical space. As the company looks to expand its international footprint, Adler’s insights are seen as vital for achieving strategic objectives.

Loan Agreement Overview


Alongside Adler's appointment, IM Cannabis entered into a loan agreement with L.I.A. Pure Capital Ltd. The pact enables IMC to receive an initial $1 million tranche as of July 9, 2025, with the potential for an additional $1 million tranche within the next 60 days, contingent on compliance with certain conditions.

The loan carries an 8% annual interest rate, plus VAT, with a repayment deadline set for June 30, 2026. Should the company default on this repayment, a 15% penalty on the outstanding loan balance will be enacted. The loan is secured by a pledge of IMC Holdings Ltd’s ownership shares, ensuring the lender's position in this transaction.

The company is also committed to raising at least $3 million within the stipulated 60-day frame through a capital offering, advised by Aegis Capital Corp. Notably, a higher sum raised would diminish the lender's obligation towards providing the second tranche, underscoring the pressure on IM Cannabis to enhance its financial position swiftly.

The Role of Pure Capital


Pure Capital, managed by Kfir Zilberman, is known for supporting innovative Israeli enterprises across diverse sectors. Their expertise not only includes financial backing but also encompasses strategic guidance from early stages through various phases of corporate growth, including public offerings. This partnership aligns with IMC’s mission of sustainable growth in an industry characterized by stringent regulatory standards.

Future Projections


With new leadership and strategic financial support in place, IM Cannabis is poised to enhance its market share in Israel and Germany's medical cannabis sectors. The company’s operational strategies underscore their commitment to responsible growth while navigating the challenges unique to cannabis regulations internationally.

Adler shared his eagerness to contribute positively to IMC, highlighting the company’s unique position within the realms of healthcare and innovation. As IM Cannabis gears up to solidify its international presence, the alignment of leadership and capital resources will be crucial in the coming months.

Conclusion


With an enriched executive team and a robust financial framework, IM Cannabis Corp. stands ready to tackle the demands of the medical cannabis market, continuing its mission of providing quality products to patients. The integration of Oz Adler into the leadership circle is a clear indicator of IMC's ambitions, reinforcing the company’s dedication to achieving its goals and benefiting its stakeholders.

Topics Consumer Products & Retail)

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.